Clinical Trials Logo

Sleep Restriction clinical trials

View clinical trials related to Sleep Restriction.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04731662 Active, not recruiting - Sleep Clinical Trials

Performance, Mood, and Brain and Metabolic Functions During Different Sleep Schedules

STAVAR
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This proposed project will investigate whether a variable or a stable sleep schedule will be more effective in minimizing neurobehavioural and metabolic deficits when total sleep opportunity across two weeks is below the recommended sleep duration. In this laboratory-based, stay-in study, 60 young adults will be randomized into 1 of 3 groups. After 2 nights of 8-h time-in-bed (TIB) that simulate longer sleep opportunities typical of weekends, the stable short sleep group will have a 6-h TIB in each of the following 5 'weeknights' (8866666). The variable short sleep group (8884846) will also have a total TIB of 30h during the 'weeknights', although TIB varies across the 'weeknights'. The nightly TIB of the well-rested control group will be 8h (8888888). These manipulations will repeat in the second week, enabling the tracking of outcome measures during recurrent weeks of sleep restriction on 'weekdays' and extension on 'weekends'. A test battery assessing basic cognitive functions and mood will be administered 5 times a day. A long-term memory encoding task will be administered after week 1. A functional Magnetic Resonance Imaging (fMRI) brain scan, and an Oral Glucose Tolerance Test (OGTT) will be conducted after the second 'weekend' night and after the last 'weeknight' each week. Continuous glucose monitoring will be conducted throughout the experiment. Sleep will be measured every night with polysomnography.

NCT ID: NCT04037605 Active, not recruiting - Sleep Restriction Clinical Trials

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

Start date: February 9, 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction and 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.

NCT ID: NCT03377543 Active, not recruiting - Inflammation Clinical Trials

Sleep and Inflammatory Resolution Pathway

Start date: June 6, 2018
Phase: Early Phase 1
Study type: Interventional

Goal of this project is to investigate whether increases in inflammation that result from common patterns of restricting sleep on week nights and catching up on sleep over the weekend are caused by disruption in the newly discovered inflammatory resolution pathways. These pathways are crucial in the active termination of the inflammatory response, and their disruption may contribute to ongoing unresolved inflammation, which has been observed not only during periods of sleep restriction, but also after recovery sleep has been obtained. If the hypothesis is true, it is possible that increasing the body's natural production of endogenous, inflammatory resolution mediators may provide a non-behavioral strategy to limit the inflammatory consequences in those undergoing periods of sleep restriction with intermittent recovery sleep.

NCT ID: NCT03142893 Active, not recruiting - Sleep Restriction Clinical Trials

Hormonal Mechanisms of Sleep Restriction - Axis Study

Start date: May 8, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.